UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
_______________________________
(Exact name of registrant as specified in its charter)
_______________________________
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of Principal Executive Offices) (Zip Code)
(
(Registrant's telephone number, including area code)
(Former name or former address, if changed since last report)
_______________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On September 2, 2021, the Registrant issued a press release, a copy of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
| 99.1 | Press Release dated September 2, 2021 | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Quanex Building Products Corporation | ||
| Date: September 2, 2021 | By: | /s/ SCOTT ZUEHLKE |
| Scott Zuehlke | ||
| SVP, CFO and Treasurer | ||
EXHIBIT 99.1
Quanex Building Products Announces Third Quarter 2021 Results and Reaffirms Full Year 2021 Guidance
Solid Net Sales Growth Realized Across All Operating Segments
Strong Balance Sheet
Liquidity Continues to Increase
Repaid $15 Million of Bank Debt
HOUSTON, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2021.
The Company reported the following selected financial results:
| QUANEX BUILDING PRODUCTS CORPORATION | |||||||||
| Q3 2021 Earnings Release | |||||||||
| Three Months Ended July 31, | Nine Months Ended July 31, | ||||||||
| ($ in millions, except per share data) | 2021 | 2020 | 2021 | 2020 | |||||
| Net Sales | $279.9 | $212.1 | $780.4 | $596.2 | |||||
| Gross Margin | $60.0 | $49.7 | $175.7 | $126.6 | |||||
| Gross Margin % | 21.4% | 23.4% | 22.5% | 21.2% | |||||
| Net Income | $13.6 | $10.8 | $36.0 | $16.3 | |||||
| Diluted EPS | $0.41 | $0.33 | $1.08 | $0.50 | |||||
| Adjusted Net Income | $14.2 | $11.1 | $37.8 | $18.7 | |||||
| Adjusted Diluted EPS | $0.42 | $0.34 | $1.13 | $0.57 | |||||
| Adjusted EBITDA | $32.9 | $27.7 | $89.5 | $65.2 | |||||
| Adjusted EBITDA Margin % | 11.8% | 13.1% | 11.5% | 10.9% | |||||
| Cash Provided by Operating Activities | $18.5 | $45.1 | $47.4 | $47.6 | |||||
| Free Cash Flow | $12.3 | $40.7 | $31.4 | $26.9 | |||||
(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and Free Cash Flow Reconciliation table for additional information)
George Wilson, President and Chief Executive Officer, stated, “Demand for our products remained robust across all of our product lines throughout the third quarter of 2021. On a consolidated basis, net sales increased by approximately 32% year-over-year as compared to the third quarter of 2020. General inflation, time lag for index pricing, supply chain challenges and labor constraints all continue to have a negative impact on margins. In addition, our plant in Germany was down for approximately 14 days during the quarter due to flooding in Europe, but the plant was back up and running at full capacity by the end of July. Our balance sheet continues to strengthen, and we were able to repay $15.0 million in bank debt during the quarter while also repurchasing approximately $1.8 million of our common stock. We will remain focused on generating cash and paying down debt in the near-term.” (See Non-GAAP Terminology Definitions and Disclaimers section for additional information)
Third Quarter 2021 Results Summary
The Company reported net sales of $279.9 million during the three months ended July 31, 2021, which represents growth of 32.0% compared to $212.1 million for the same period of 2020. The increase was largely due to increased demand across all product lines and operating segments combined with increased pricing mostly related to the pass through of raw material cost inflation. In detail, Quanex posted net sales growth of 20.8% in its North American Fenestration segment, 19.3% in its North American Cabinet Components segment and 85.8% in its European Fenestration segment, excluding the foreign exchange impact and despite the challenges presented by flooding in Germany as previously noted. As a reminder, both of Quanex’s manufacturing facilities in the U.K. were shut down in late March of 2020 and did not resume operations until mid-to-late May 2020. (See Sales Analysis table for additional information)
The increase in earnings for the third quarter of 2021 was mainly due to higher volumes and improved operating leverage. This increase was somewhat offset by inflationary pressures and an increase in selling, general and administrative expenses, which was mostly attributable to more normalized medical costs combined with an increase in stock-based compensation expense.
Balance Sheet & Liquidity Update
As of July 31, 2021, Quanex had total debt of $74.0 million and its leverage ratio of Net Debt to LTM Adjusted EBITDA improved to 0.2x. (See Non-GAAP Terminology Definitions and Disclaimers section and Net Debt and LTM Adjusted EBITDA reconciliation tables for additional information)
The Company’s liquidity increased to $306.2 million as of July 31, 2021, consisting of $43.7 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2023, less letters of credit outstanding.
Share Repurchases
Quanex’s Board of Directors authorized a $60 million share repurchase program in September of 2018. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The program does not have an expiration date or a limit on the number of shares that may be repurchased. The Company repurchased 74,257 shares of common stock for approximately $1.8 million at an average price of $23.88 per share during the three months ended July 31, 2021. As of July 31, 2021, approximately $5.4 million remained under the existing share repurchase authorization.
Outlook
George Wilson, President and Chief Executive Officer, commented, “While we remain optimistic on the demand outlook for our products, we do expect inflation, labor costs, and supply chain challenges to continue pressuring margins throughout the fourth quarter of this year. We continue to pass these incremental costs along to our customers through indexes, surcharges, and price increases; however, there are time lags in each case. With this backdrop, on a consolidated basis, we are reaffirming net sales guidance of approximately $1.04 billion to $1.06 billion and Adjusted EBITDA* of $125 million to $130 million in fiscal 2021.”
*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.
Conference Call and Webcast Information
The Company has scheduled a conference call for Friday, September 3, 2021, at 11:00 a.m. ET (10:00 a.m. CT). To participate in the conference call dial (877) 388-2139 for domestic callers and (541) 797-2983 for international callers, in both cases using the conference passcode 6642169, and ask for the Quanex call a few minutes prior to the start time. A link to the live audio webcast will also be available on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events. A telephonic replay of the call will be available approximately two hours after the live broadcast ends and will be accessible through September 10, 2021. To access the replay dial (855) 859-2056 for domestic callers and (404) 537-3406 for international callers, in both cases referencing conference passcode 6642169.
About Quanex
Quanex Building Products Corporation is an industry-leading manufacturer of components sold to Original Equipment Manufacturers (OEMs) in the building products industry. Quanex designs and produces energy-efficient fenestration products in addition to kitchen and bath cabinet components. For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.
Non-GAAP Terminology Definitions and Disclaimers
Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) and Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making. Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement. Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of Quanex’s residual cash flow available for discretionary expenditures. The Company believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding Quanex’s financial performance when comparing results to other investment opportunities. The presented non-GAAP measures may not be the same as those used by other companies. The Company does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.
Forward Looking Statements
Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex’s products, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2020, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
| Three Months Ended July 31, | Nine Months Ended July 31, | |||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||
| Net sales | $ | 279,877 | $ | 212,096 | $ | 780,381 | $ | 596,168 | ||||||||
| Cost of sales | 219,866 | 162,427 | 604,723 | 469,586 | ||||||||||||
| Selling, general and administrative | 27,766 | 21,973 | 88,299 | 62,818 | ||||||||||||
| Restructuring charges | - | 73 | 39 | 477 | ||||||||||||
| Depreciation and amortization | 10,683 | 11,060 | 32,543 | 35,851 | ||||||||||||
| Operating income | 21,562 | 16,563 | 54,777 | 27,436 | ||||||||||||
| Interest expense | (597 | ) | (1,165 | ) | (1,988 | ) | (4,310 | ) | ||||||||
| Other, net | 188 | (220 | ) | 645 | 116 | |||||||||||
| Income before income taxes | 21,153 | 15,178 | 53,434 | 23,242 | ||||||||||||
| Income tax expense | (7,474 | ) | (4,345 | ) | (17,352 | ) | (6,898 | ) | ||||||||
| Net income | $ | 13,679 | $ | 10,833 | $ | 36,082 | $ | 16,344 | ||||||||
| Earnings per common share, basic | $ | 0.41 | $ | 0.33 | $ | 1.09 | $ | 0.50 | ||||||||
| Earnings per common share, diluted | $ | 0.41 | $ | 0.33 | $ | 1.08 | $ | 0.50 | ||||||||
| Weighted average common shares outstanding: | ||||||||||||||||
| Basic | 33,359 | 32,610 | 33,194 | 32,716 | ||||||||||||
| Diluted | 33,650 | 32,739 | 33,518 | 32,845 | ||||||||||||
| Cash dividends per share | $ | 0.08 | $ | 0.08 | $ | 0.24 | $ | 0.24 | ||||||||
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
| July 31, 2021 | October 31, 2020 | |||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash and cash equivalents | $ | 43,663 | $ | 51,621 | ||||
| Accounts receivable, net | 98,286 | 88,287 | ||||||
| Inventories, net | 93,493 | 61,181 | ||||||
| Prepaid and other current assets | 9,133 | 6,217 | ||||||
| Total current assets | 244,575 | 207,306 | ||||||
| Property, plant and equipment, net | 176,032 | 184,104 | ||||||
| Operating lease right-of-use assets | 54,811 | 51,824 | ||||||
| Goodwill | 150,487 | 146,154 | ||||||
| Intangible assets, net | 86,026 | 93,068 | ||||||
| Other assets | 7,261 | 9,129 | ||||||
| Total assets | $ | 719,192 | $ | 691,585 | ||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 79,167 | $ | 77,335 | ||||
| Accrued liabilities | 52,751 | 38,289 | ||||||
| Income taxes payable | 1,327 | 6,465 | ||||||
| Current maturities of long-term debt | 839 | 692 | ||||||
| Current operating lease liabilities | 8,270 | 7,459 | ||||||
| Total current liabilities | 142,354 | 130,240 | ||||||
| Long-term debt | 72,439 | 116,728 | ||||||
| Noncurrent operating lease liabilities | 47,371 | 44,873 | ||||||
| Deferred pension and postretirement benefits | 10,765 | 10,923 | ||||||
| Deferred income taxes | 25,252 | 19,116 | ||||||
| Other liabilities | 15,622 | 13,946 | ||||||
| Total liabilities | 313,803 | 335,826 | ||||||
| Stockholders’ equity: | ||||||||
| Common stock | 373 | 373 | ||||||
| Additional paid-in-capital | 253,662 | 253,458 | ||||||
| Retained earnings | 241,582 | 213,517 | ||||||
| Accumulated other comprehensive loss | (22,968 | ) | (33,024 | ) | ||||
| Treasury stock at cost | (67,260 | ) | (78,565 | ) | ||||
| Total stockholders’ equity | 405,389 | 355,759 | ||||||
| Total liabilities and stockholders' equity | $ | 719,192 | $ | 691,585 | ||||
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
| Nine Months Ended July 31, | |||||||
| 2021 | 2020 | ||||||
| Operating activities: | |||||||
| Net income | $ | 36,082 | $ | 16,344 | |||
| Adjustments to reconcile net income to cash provided by operating activities: | |||||||
| Depreciation and amortization | 32,543 | 35,851 | |||||
| Stock-based compensation | 1,470 | 513 | |||||
| Deferred income tax | 5,429 | 438 | |||||
| Other, net | 5,485 | 762 | |||||
| Changes in assets and liabilities: | |||||||
| Increase in accounts receivable | (8,277 | ) | (1,852 | ) | |||
| (Increase) decrease in inventory | (32,113 | ) | 3,553 | ||||
| (Increase) decrease in other current assets | (2,768 | ) | 1,218 | ||||
| Increase (decrease) in accounts payable | 1,600 | (1,878 | ) | ||||
| Increase (decrease) in accrued liabilities | 12,521 | (7,611 | ) | ||||
| (Decrease) increase in income taxes payable | (5,158 | ) | 107 | ||||
| (Decrease) increase in deferred pension and postretirement benefits | (158 | ) | 573 | ||||
| Increase (decrease) in other long-term liabilities | 962 | (181 | ) | ||||
| Other, net | (183 | ) | (276 | ) | |||
| Cash provided by operating activities | 47,435 | 47,561 | |||||
| Investing activities: | |||||||
| Capital expenditures | (16,006 | ) | (20,673 | ) | |||
| Proceeds from disposition of capital assets | 3,138 | 131 | |||||
| Cash used for investing activities | (12,868 | ) | (20,542 | ) | |||
| Financing activities: | |||||||
| Borrowings under credit facilities | - | 114,500 | |||||
| Repayments of credit facility borrowings | (45,000 | ) | (119,000 | ) | |||
| Repayments of other long-term debt | (502 | ) | (791 | ) | |||
| Common stock dividends paid | (8,017 | ) | (7,910 | ) | |||
| Issuance of common stock | 16,272 | 2,954 | |||||
| Payroll tax paid to settle shares forfeited upon vesting of stock | (492 | ) | (454 | ) | |||
| Purchase of treasury stock | (5,741 | ) | (6,693 | ) | |||
| Cash used for financing activities | (43,480 | ) | (17,394 | ) | |||
| Effect of exchange rate changes on cash and cash equivalents | 955 | 580 | |||||
| (Decrease) increase in cash and cash equivalents | (7,958 | ) | 10,205 | ||||
| Cash and cash equivalents at beginning of period | 51,621 | 30,868 | |||||
| Cash and cash equivalents at end of period | $ | 43,663 | $ | 41,073 | |||
QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATIONS
(In thousands)
(Unaudited)
| The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures. | |||||||||||||||||
| Three Months Ended July 31, | Nine Months Ended July 31, | ||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | ||||||||||||||
| Cash provided by operating activities | 18,475 | $45,089 | $47,435 | $47,561 | |||||||||||||
| Capital expenditures | (6,207) | (4,360) | (16,006) | (20,673) | |||||||||||||
| Free Cash Flow | $12,268 | $40,729 | $31,429 | $26,888 | |||||||||||||
| The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash. | |||||||||||||||||
| As of July 31, | |||||||||||||||||
| 2021 | 2020 | ||||||||||||||||
| Revolving Credit Facility | $58,000 | $138,000 | |||||||||||||||
| Finance Lease Obligations | 15,951 | 15,729 | |||||||||||||||
| Total Debt (1) | 73,951 | 153,729 | |||||||||||||||
| Less: Cash and cash equivalents | 43,663 | 41,073 | |||||||||||||||
| Net Debt | $30,288 | $112,656 | |||||||||||||||
| (1) Excludes outstanding letters of credit. | |||||||||||||||||
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
| Three Months Ended | Three Months Ended | Nine Months Ended | Nine Months Ended | ||||||||||||||||||||||||||||||||||
| Reconciliation of Adjusted Net Income and Adjusted EPS | July 31, 2021 | July 31, 2020 | July 31, 2021 | July 31, 2020 | |||||||||||||||||||||||||||||||||
| Net Income | Diluted EPS | Net Income | Diluted EPS | Net Income | Diluted EPS | Net Loss | Diluted EPS | ||||||||||||||||||||||||||||||
| Net income as reported | $ | 13,679 | $ | 0.41 | $ | 10,833 | $ | 0.33 | $ | 36,082 | $ | 1.08 | $ | 16,344 | $ | 0.50 | |||||||||||||||||||||
| Net Income reconciling items from below | 512 | 0.01 | 280 | 0.01 | 1,686 | 0.05 | 2,387 | 0.07 | |||||||||||||||||||||||||||||
| Adjusted net income and adjusted EPS | $ | 14,191 | $ | 0.42 | $ | 11,113 | $ | 0.34 | $ | 37,768 | $ | 1.13 | $ | 18,731 | $ | 0.57 | |||||||||||||||||||||
| Reconciliation of Adjusted EBITDA | Three Months Ended July 31, 2021 | Three Months Ended July 31, 2020 | Nine Months Ended July 31, 2021 | Nine Months Ended July 31, 2020 | |||||||||||||||||||||||||||||||||
| Reconciliation | Reconciliation | Reconciliation | Reconciliation | ||||||||||||||||||||||||||||||||||
| Net income as reported | $ | 13,679 | $ | 10,833 | $ | 36,082 | $ | 16,344 | |||||||||||||||||||||||||||||
| Income tax expense | 7,474 | 4,345 | 17,352 | 6,898 | |||||||||||||||||||||||||||||||||
| Other, net | (188 | ) | 220 | (645 | ) | (116 | ) | ||||||||||||||||||||||||||||||
| Interest expense | 597 | 1,165 | 1,988 | 4,310 | |||||||||||||||||||||||||||||||||
| Depreciation and amortization | 10,683 | 11,060 | 32,543 | 35,851 | |||||||||||||||||||||||||||||||||
| EBITDA | 32,245 | 27,623 | 87,320 | 63,287 | |||||||||||||||||||||||||||||||||
| EBITDA reconciling items from below | 682 | 73 | 2,160 | 1,875 | |||||||||||||||||||||||||||||||||
| Adjusted EBITDA | $ | 32,927 | $ | 27,696 | $ | 89,480 | $ | 65,162 | |||||||||||||||||||||||||||||
| Reconciling Items | Three Months Ended July 31, 2021 | Three Months Ended July 31, 2020 | Nine Months Ended July 31, 2021 | Nine Months Ended July 31, 2020 | |||||||||||||||||||||||||||||||||
| Income Statement | Reconciling Items | Income Statement | Reconciling Items | Income Statement | Reconciling Items | Income Statement | Reconciling Items | ||||||||||||||||||||||||||||||
| Net sales | $ | 279,877 | $ | - | $ | 212,096 | $ | - | $ | 780,381 | $ | - | $ | 596,168 | $ | - | |||||||||||||||||||||
| Cost of sales | 219,866 | (307 | ) | (1 | ) | 162,427 | - | 604,723 | (307 | ) | (1 | ) | 469,586 | - | |||||||||||||||||||||||
| Selling, general and administrative | 27,766 | (375 | ) | (2 | ) | 21,973 | - | 88,299 | (1,814 | ) | (2 | ) | 62,818 | (1,398 | ) | (2 | ) | ||||||||||||||||||||
| Restructuring charges | - | - | 73 | (73 | ) | (3 | ) | 39 | (39 | ) | (3 | ) | 477 | (477 | ) | (3 | ) | ||||||||||||||||||||
| EBITDA | 32,245 | 682 | 27,623 | 73 | 87,320 | 2,160 | 63,287 | 1,875 | |||||||||||||||||||||||||||||
| Depreciation and amortization | 10,683 | - | 11,060 | - | 32,543 | - | 35,851 | (968 | ) | (4 | ) | ||||||||||||||||||||||||||
| Operating income | 21,562 | 682 | 16,563 | 73 | 54,777 | 2,160 | 27,436 | 2,843 | |||||||||||||||||||||||||||||
| Interest expense | (597 | ) | - | (1,165 | ) | - | (1,988 | ) | - | (4,310 | ) | - | |||||||||||||||||||||||||
| Other, net | 188 | 79 | (5 | ) | (220 | ) | 458 | (5 | ) | 645 | 161 | (5 | ) | 116 | 390 | (5 | ) | ||||||||||||||||||||
| Income before income taxes | 21,153 | 761 | 15,178 | 531 | 53,434 | 2,321 | 23,242 | 3,233 | |||||||||||||||||||||||||||||
| Income tax expense | (7,474 | ) | (249 | ) | (6 | ) | (4,345 | ) | (251 | ) | (6 | ) | (17,352 | ) | (635 | ) | (6 | ) | (6,898 | ) | (846 | ) | (6 | ) | |||||||||||||
| Net income | $ | 13,679 | $ | 512 | $ | 10,833 | $ | 280 | $ | 36,082 | $ | 1,686 | $ | 16,344 | $ | 2,387 | |||||||||||||||||||||
| Diluted earnings per share | $ | 0.41 | $ | 0.33 | $ | 1.08 | $ | 0.50 | |||||||||||||||||||||||||||||
| (1) Loss on damage to a plant caused by flooding of $0.3 million for the three and nine months ended July 31, 2021. | |||||||||||||||||||||||||||||||||||||
| (2) Transaction and advisory fees, $0.4 million related to the loss on a sale of a plant in the three months ended July 31, 2021, $1.8 million related to the loss on a sale of a plant in the nine months ended July 31, 2021, $1.3 million related to executive severance charges in the nine months ended July 31, 2020, respectively. | |||||||||||||||||||||||||||||||||||||
| (3) Restructuring charges related to the closure of manufacturing plant facilities. | |||||||||||||||||||||||||||||||||||||
| (4) Accelerated depreciation related to the closure of a North American Cabinet Components plant. | |||||||||||||||||||||||||||||||||||||
| (5) Foreign currency transaction losses. | |||||||||||||||||||||||||||||||||||||
| (6) Impact on a with and without basis. | |||||||||||||||||||||||||||||||||||||
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands)
(Unaudited)
| Reconciliation of Last Twelve Months Adjusted EBITDA | Three Months Ended July 31, 2021 | Three Months Ended April 30, 2021 | Three Months Ended January 31, 2021 | Three Months Ended October 31, 2020 | Total | |||||||||||||||
| Reconciliation | Reconciliation | Reconciliation | Reconciliation | Reconciliation | ||||||||||||||||
| Net income as reported | $ | 13,679 | $ | 14,551 | $ | 7,852 | $ | 22,152 | $ | 58,234 | ||||||||||
| Income tax expense | 7,474 | 6,454 | 3,424 | 4,906 | 22,258 | |||||||||||||||
| Other, net | (188 | ) | (265 | ) | (192 | ) | (164 | ) | (809 | ) | ||||||||||
| Interest expense | 597 | 640 | 751 | 935 | 2,923 | |||||||||||||||
| Depreciation and amortization | 10,683 | 10,845 | 11,015 | 11,378 | 43,921 | |||||||||||||||
| EBITDA | 32,245 | 32,225 | 22,850 | 39,207 | 126,527 | |||||||||||||||
| Cost of sales (1) | 307 | - | - | - | 307 | |||||||||||||||
| Selling, general and administrative (2) | 375 | - | 1,439 | - | 1,814 | |||||||||||||||
| Restructuring charges (3) | - | - | 39 | 145 | 184 | |||||||||||||||
| Adjusted EBITDA | $ | 32,927 | $ | 32,225 | $ | 24,328 | $ | 39,352 | $ | 128,832 | ||||||||||
| (1) Loss on the damage of a plant caused by flooding. | ||||||||||||||||||||
| (2) Transaction and advisory fees, loss on the sale of a plant, and executive severance charges. | ||||||||||||||||||||
| (3) Restructuring charges relate to the closure of manufacturing plant facilities. | ||||||||||||||||||||
QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
| This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments. | ||||||||||||||||||||
| NA Fenestration | EU Fenestration | NA Cabinet Components | Unallocated Corp & Other | Total | ||||||||||||||||
| Three months ended July 31, 2021 | ||||||||||||||||||||
| Net sales | $ | 147,818 | $ | 71,114 | $ | 61,936 | $ | (991 | ) | $ | 279,877 | |||||||||
| Cost of sales | 116,517 | 49,479 | 54,334 | (464 | ) | 219,866 | ||||||||||||||
| Gross Margin | 31,301 | 21,635 | 7,602 | (527 | ) | 60,011 | ||||||||||||||
| Gross Margin % | 21.2% | 30.4% | 12.3% | 21.4% | ||||||||||||||||
| Selling, general and administrative | 13,428 | 7,525 | 5,130 | 1,683 | 27,766 | |||||||||||||||
| Depreciation and amortization | 4,571 | 2,646 | 3,390 | 76 | 10,683 | |||||||||||||||
| Operating income (loss) | 13,302 | 11,464 | (918 | ) | (2,286 | ) | 21,562 | |||||||||||||
| Depreciation and amortization | 4,571 | 2,646 | 3,390 | 76 | 10,683 | |||||||||||||||
| EBITDA | 17,873 | 14,110 | 2,472 | (2,210 | ) | 32,245 | ||||||||||||||
| Loss on the damage of a plant | - | 307 | - | - | 307 | |||||||||||||||
| Loss on sale of plant | 375 | - | - | - | 375 | |||||||||||||||
| Adjusted EBITDA | $ | 18,248 | $ | 14,417 | $ | 2,472 | $ | (2,210 | ) | $ | 32,927 | |||||||||
| Adjusted EBITDA Margin % | 12.3% | 20.3% | 4.0% | 11.8% | ||||||||||||||||
| Three months ended July 31, 2020 | ||||||||||||||||||||
| Net sales | $ | 122,386 | $ | 38,265 | $ | 51,925 | $ | (480 | ) | $ | 212,096 | |||||||||
| Cost of sales | 92,639 | 25,845 | 44,218 | (275 | ) | 162,427 | ||||||||||||||
| Gross Margin | 29,747 | 12,420 | 7,707 | (205 | ) | 49,669 | ||||||||||||||
| Gross Margin % | 24.3% | 32.5% | 14.8% | 23.4% | ||||||||||||||||
| Selling, general and administrative | 11,922 | 4,748 | 4,634 | 669 | 21,973 | |||||||||||||||
| Restructuring charges | 71 | - | 2 | - | 73 | |||||||||||||||
| Depreciation and amortization | 5,371 | 2,307 | 3,264 | 118 | 11,060 | |||||||||||||||
| Operating income (loss) | 12,383 | 5,365 | (193 | ) | (992 | ) | 16,563 | |||||||||||||
| Depreciation and amortization | 5,371 | 2,307 | 3,264 | 118 | 11,060 | |||||||||||||||
| EBITDA | 17,754 | 7,672 | 3,071 | (874 | ) | 27,623 | ||||||||||||||
| Restructuring charges | 71 | - | 2 | - | 73 | |||||||||||||||
| Adjusted EBITDA | $ | 17,825 | $ | 7,672 | $ | 3,073 | $ | (874 | ) | $ | 27,696 | |||||||||
| Adjusted EBITDA Margin % | 14.6% | 20.0% | 5.9% | 13.1% | ||||||||||||||||
| Nine months ended July 31, 2021 | ||||||||||||||||||||
| Net sales | $ | 422,077 | $ | 181,862 | $ | 179,492 | $ | (3,050 | ) | $ | 780,381 | |||||||||
| Cost of sales | 328,278 | 122,631 | 155,370 | (1,556 | ) | 604,723 | ||||||||||||||
| Gross Margin | 93,799 | 59,231 | 24,122 | (1,494 | ) | 175,658 | ||||||||||||||
| Gross Margin % | 22.2% | 32.6% | 13.4% | 22.5% | ||||||||||||||||
| Selling, general and administrative | 38,944 | 21,559 | 15,372 | 12,424 | 88,299 | |||||||||||||||
| Restructuring charges | 39 | - | - | - | 39 | |||||||||||||||
| Depreciation and amortization | 14,528 | 7,771 | 9,965 | 279 | 32,543 | |||||||||||||||
| Operating income (loss) | 40,288 | 29,901 | (1,215 | ) | (14,197 | ) | 54,777 | |||||||||||||
| Depreciation and amortization | 14,528 | 7,771 | 9,965 | 279 | 32,543 | |||||||||||||||
| EBITDA | 54,816 | 37,672 | 8,750 | (13,918 | ) | 87,320 | ||||||||||||||
| Loss on the damage of a plant | - | 307 | - | - | 307 | |||||||||||||||
| Loss on sale of plant | 375 | - | - | 1,439 | 1,814 | |||||||||||||||
| Restructuring charges | 39 | - | - | - | 39 | |||||||||||||||
| Adjusted EBITDA | $ | 55,230 | $ | 37,979 | $ | 8,750 | $ | (12,479 | ) | $ | 89,480 | |||||||||
| Adjusted EBITDA Margin % | 13.1% | 20.9% | 4.9% | 11.5% | ||||||||||||||||
| Nine months ended July 31, 2020 | ||||||||||||||||||||
| Net sales | $ | 341,432 | $ | 104,230 | $ | 152,634 | $ | (2,128 | ) | $ | 596,168 | |||||||||
| Cost of sales | 266,489 | 72,055 | 132,259 | (1,217 | ) | 469,586 | ||||||||||||||
| Gross Margin | 74,943 | 32,175 | 20,375 | (911 | ) | 126,582 | ||||||||||||||
| Gross Margin % | 21.9% | 30.9% | 13.3% | 21.2% | ||||||||||||||||
| Selling, general and administrative | 34,962 | 15,990 | 13,468 | (1,602 | ) | 62,818 | ||||||||||||||
| Restructuring charges | 228 | - | 249 | - | 477 | |||||||||||||||
| Depreciation and amortization | 18,311 | 7,045 | 10,139 | 356 | 35,851 | |||||||||||||||
| Operating income (loss) | 21,442 | 9,140 | (3,481 | ) | 335 | 27,436 | ||||||||||||||
| Depreciation and amortization | 18,311 | 7,045 | 10,139 | 356 | 35,851 | |||||||||||||||
| EBITDA | 39,753 | 16,185 | 6,658 | 691 | 63,287 | |||||||||||||||
| Transaction and advisory fees | - | - | - | 55 | 55 | |||||||||||||||
| Executive severance charges | - | - | - | 1,343 | 1,343 | |||||||||||||||
| Restructuring charges | 228 | - | 249 | - | 477 | |||||||||||||||
| Adjusted EBITDA | $ | 39,981 | $ | 16,185 | $ | 6,907 | $ | 2,089 | $ | 65,162 | ||||||||||
| Adjusted EBITDA Margin % | 11.7% | 15.5% | 4.5% | 10.9% | ||||||||||||||||
QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| July 31, 2021 | July 31, 2020 | July 31, 2021 | July 31, 2020 | |||||||||||||
| NA Fenestration: | ||||||||||||||||
| United States - fenestration | $ | 129,291 | $ | 109,455 | $ | 369,809 | $ | 302,094 | ||||||||
| International - fenestration | 9,581 | 6,696 | 25,756 | 19,284 | ||||||||||||
| United States - non-fenestration | 5,853 | 4,845 | 17,543 | 13,779 | ||||||||||||
| International - non-fenestration | 3,093 | 1,390 | 8,969 | 6,275 | ||||||||||||
| $ | 147,818 | $ | 122,386 | $ | 422,077 | $ | 341,432 | |||||||||
| EU Fenestration (1): | ||||||||||||||||
| International - fenestration | $ | 54,883 | $ | 31,904 | $ | 147,072 | $ | 87,732 | ||||||||
| International - non-fenestration | 16,231 | 6,361 | 34,790 | 16,498 | ||||||||||||
| $ | 71,114 | $ | 38,265 | $ | 181,862 | $ | 104,230 | |||||||||
| NA Cabinet Components: | ||||||||||||||||
| United States - fenestration | $ | 3,240 | $ | 2,666 | $ | 9,711 | $ | 8,461 | ||||||||
| United States - non-fenestration | 57,418 | 48,849 | 168,308 | 142,838 | ||||||||||||
| International - non-fenestration | 1,278 | 410 | 1,473 | 1,335 | ||||||||||||
| $ | 61,936 | $ | 51,925 | $ | 179,492 | $ | 152,634 | |||||||||
| Unallocated Corporate & Other: | ||||||||||||||||
| Eliminations | $ | (991 | ) | $ | (480 | ) | $ | (3,050 | ) | $ | (2,128 | ) | ||||
| $ | (991 | ) | $ | (480 | ) | $ | (3,050 | ) | $ | (2,128 | ) | |||||
| Net Sales | $ | 279,877 | $ | 212,096 | $ | 780,381 | $ | 596,168 | ||||||||
| (1) Reflects increase of $4.1 million and $8.6 million in revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2021, respectively. | ||||||||||||||||